No internet connection — showing the saved version of the page.

Elevance Health I…

USUSD
← to the screener
US:ELVLSE:0HG8

Elevance Health Inc (LSE:0HG8) — Medical Specialities. Number of exchanges where the company shares trade: 2. On this page — price and chart, dividends, top holders and share count history.

About the company

Website
elevancehealth.com
Investor relations
ir.elevancehealth.com/
Sector
Health Care · Medical Specialities
Headquarters
Indianapolis, United States
CEO
Gail Boudreaux
Employees
96 129
Founded
1940
Shares outstanding
216.06 M as of 2026-10-15
DateSharesChange
15.10.2026216.06 M−0.4%buyback
10.07.2026216.87 M
Share count from the company reports. A split is detected by a jump in the count by a whole number of times.
Free float
216.37 M
Market cap
85.17 B USD
Insiders
0.19%
Institutions
94.15%
Industry (SIC)
Hospital & Medical Service Plans
Legal form
R0BI
ISIN
US0367521038
LEI
8MYN82XMYQH89CTMTH67
P/E
15.6
P/B
2.13
Payout ratio
30.4%
FCF
6.29 B USD
Payout / FCF
24%
Debt
31.0 B USD
3.3 y of FCF
Dividend streak
15 y
Earnings, FCF and dividends paid — for the 12 months to 30.06.2026 (the company's latest report).
NAV
207 USD · P/NAV 1.92
Balance sheet date30.06.2026
Assets126 B USD
− Liabilities81.4 B USD
= Total equity45.0 B USD
− Non-controlling interests139 M USD
= NAV (equity of the company's shareholders)44.9 B USD
− Goodwill28.3 B USD
− Intangible assets11.0 B USD
= Tangible NAV5.56 B USD
Shares216 841 146
NAV per share207 USD
Tangible NAV per share25.65 USD
Share price (0HG8)396.73 USD
P/NAV1.92
NAV history
Balance sheet dateNAVNAV per share
30.06.202644.9 B USD207 USD
31.03.202643.9 B USD202 USD
31.12.202543.9 B USD199 USD
30.09.202544.0 B USD198 USD
30.06.202543.7 B USD194 USD
31.03.202542.5 B USD188 USD
31.12.202441.3 B USD182 USD
30.09.202443.8 B USD189 USD
Description

Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, and supplemental health insurance benefits. The company also operates in the pharmacy services business; and markets and offers pharmacy services, including home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services, as well as infusion services and injectable therapies through ambulatory infusion centers. In addition, it provides healthcare related services and capabilities, including specialty care enablement and utilization management support for specialized clinical domains; behavioral health and comprehensive care management services; palliative care services and management; virtual care; and payment integrity, subrogation, clinical data exchange through its HealthOS platform, research and data, reporting and clinical analytics, information technology, and business process support services, as well as manages home health, post-acute institutional management, and durable medical equipment costs; and supports plans in managing home and community-based services. The company provides its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brands. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was incorporated in 2001 and is based in Indianapolis, Indiana.

advertisement

Exchanges and tickers

ExchangeTickerCurrencyPriceType
US USA StocksELV primaryUSD439.95 -1.20%common stock
LSE London Stock Exchange0HG8 IOBUSD396.73 +0.00%common stock

Price for 3 months

up day down day dividend ex-date payment dateHover / tap a day — open, close, high and low prices

Dividends

Next ex-date: 2026-12-04 · 1.72 USD (US:ELV)
Per year, US:ELV: 6.88 USD (4 paym.)

Elevance Health Inc (ELV) pays dividends quarterly. Per year (12 months up to and including the latest announced payment): 6.88 USD per share (payments: 4). That is about 1.56% of the current share price. The next ex-dividend date is 04.12.2026: 1.72 USD per share, paid on 18.12.2026. Uninterrupted dividend history: 15 years.

Ex-datePaymentAmount%TypeTicker
2026-12-04 announced2026-12-181.7200 USD0.4/1.6 %quarterlyUS:ELV
2026-09-102026-09-251.7200 USD0.4/1.7 %quarterlyUS:ELV
2026-06-102026-06-251.7200 USD0.4/1.6 %quarterlyUS:ELV
2026-03-102026-03-251.7200 USD0.6/2.4 %quarterlyUS:ELV
2025-12-052025-12-191.7100 USD0.5/2.1 %quarterlyUS:ELV
2025-09-102025-09-251.7100 USD0.5/2.1 %quarterlyUS:ELV
2025-06-102025-06-251.7100 USD0.4/1.7 %quarterlyUS:ELV
2025-03-102025-03-251.7100 USD0.4/1.6 %quarterlyUS:ELV
2024-12-052024-12-201.6300 USD0.4/1.6 %quarterlyUS:ELV
2024-09-102024-09-251.6300 USD0.4/1.4 %quarterlyUS:ELV
2024-06-102024-06-251.6300 USD0.4/1.4 %quarterlyUS:ELV
2024-03-072024-03-221.6300 USD0.4/1.4 %quarterlyUS:ELV
2023-12-052023-12-211.4800 USD0.3/1.3 %quarterlyUS:ELV
2023-09-072023-09-221.4800 USD0.3/1.3 %quarterlyUS:ELV
2023-06-082023-06-231.4800 USD0.3/1.3 %quarterlyUS:ELV
2023-03-092023-03-241.4800 USD0.3/1.2 %quarterlyUS:ELV
2022-12-022022-12-211.2800 USD0.3/1.2 %quarterlyUS:ELV
2022-09-082022-09-231.2800 USD0.3/1.1 %quarterlyUS:ELV
2022-06-092022-06-241.2800 USD0.3/0.8 %quarterlyUS:ELV
2022-03-092022-03-251.2800 USD0.3/0.5 %quarterlyUS:ELV
2021-12-022021-12-211.1300 USD0.3/0.3 %quarterlyUS:ELV

News this week

Press releases from the company's investor website, updated daily. Links lead to the company's website. Headlines are in the original language, as on the company website.

Top holders

HolderStakeSharesReport date
Blackrock Inc.8.76%18.99 M2026-06-30
Vanguard Capital Managem…6.48%14.06 M2026-06-30
State Street Corporation4.81%10.43 M2026-06-30
Wellington Management Gr…4.25%9.21 M2026-06-30
VANGUARD INDEX FUNDS-Van…3.05%6.61 M2026-06-30
Vanguard Portfolio Manag…2.87%6.21 M2026-06-30
Sanders Capital, LLC2.69%5.83 M2026-06-30
VANGUARD INDEX FUNDS-Van…2.49%5.39 M2026-06-30
Geode Capital Management…2.38%5.17 M2026-06-30
Harris Associates L.P.2.27%4.92 M2026-06-30
Artisan Partners Limited…2.11%4.58 M2026-06-30
Invesco Ltd.1.95%4.23 M2026-06-30
VANGUARD WINDSOR FUNDS-V…1.4%3.04 M2026-07-31
iShares Trust-iShares Co…1.33%2.89 M2026-08-31
First Eagle Funds-First…1.31%2.84 M2026-07-31
Fidelity Concord Street…1.29%2.81 M2026-07-31
SPDR S&P 500 ETF TRUST-S…1.23%2.66 M2026-08-31
VANGUARD FENWAY FUNDS-Va…0.94%2.05 M2026-06-30
VANGUARD INDEX FUNDS-Van…0.93%2.02 M2026-06-30
VANGUARD SPECIALIZED FUN…0.86%1.86 M2026-07-31
BOUDREAUX GAIL A KOZIARA…≈0.08%172 0362026-07-17
BOUDREAUX GAIL KOZIARA (…≈0.08%169 3112026-03-02
NORWOOD FELICIA F. (Offi…≈0.02%38 8382026-03-02
KAYE MARK (Chief Financi…≈0.01%32 0372026-03-02
HAYTAIAN PETER D (Office…≈0.01%27 2222026-03-02
LAVU RATNAKAR (Chief Tec…≈0.01%16 1492026-03-02
HAY LEWIS III (Director)≈0.01%12 0702026-05-13
KENDRICK CHARLES MORGAN…≈0.01%11 7912026-03-06
PERU RAMIRO G (Director)≈0.01%10 9082026-07-17
DIXON ROBERT L JR (Direc…≈0%10 7342026-06-11